<Suppliers Price>

Sugemalimab

Names

[ CAS No. ]:
2256084-03-2

[ Name ]:
Sugemalimab

Biological Activity

[Description]:

Sugemalimab is a fully human, full length, anti-programmed death ligand 1 (PD-L1) immunoglobulin G4 (IgG4) monoclonal antibody (mAb). Sugemalimab shows anticancer activities and can be used for non-small cell lung cancer research[1].

[Related Catalog]:

Research Areas >> Cancer
Signaling Pathways >> Immunology/Inflammation >> PD-1/PD-L1

[References]

[1]. Dhillon S, et al. Sugemalimab: First Approval. Drugs. 2022 Apr;82(5):593-599.

Chemical & Physical Properties

No Any Chemical & Physical Properties

Related Compounds